No change with significant differences: hepatic steatosis and fibrosis levels as measured by transient elastography, LiverFAST analysis (steatosis, fibrosis and inflammation scores), ALT, TC, TG, fasting glucose, CD4+ T lymphocytes, CD8+ T lymphocytes and ZO-1. The gene discussed is GPT; the disease is fatty liver disease.